“Image-based” Vascular Phenotyping In Cancer, Tissue Engineering And Neuroscience”
Please join us for a seminar with associate faculty member Arvind Pathak.
Zoom link: https://wse.zoom.us/s/97783644656
Webinar ID: 977 8364 4656
Password: 501459
Abstract
This lecture will highlight the development of multiscale and multimodality imaging approaches in conjunction with novel computational and visualization tools to revolutionize our understanding of the role of blood vessels in cancer, tissue engineering and neuroscience applications. This lecture will showcase new functional imaging methods; image-based systems biology approaches; and the design of new imaging systems and software tools for characterizing the vascular microenvironment. Collectively, these innovations herald a new era in “image-based” phenotyping in preclinical models.
Biography
Dr. Arvind P. Pathak is Associate Professor of Radiology and Oncology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. His work focuses on developing new imaging methods, computational models and visualization tools to ‘make visible’ critical aspects of cancer, neurobiology and tissue engineering.
Dr. Pathak received his BS in electronics engineering from the University of Poona, India, in 1993, and in 2001 completed his PhD in Functional Imaging from the joint graduate program between the Biophysics Department at the Medical College of Wisconsin and the Biomedical Engineering Dept at Marquette University. During his PhD he was the recipient of a Whitaker Fellowship. After a postdoctoral fellowship in the Molecular Imaging Program at Johns Hopkins University, he joined the Johns Hopkins faculty in 2003.
Dr. Pathak’s research has been recognized by several awards and journal covers. These include the Bill Negendank Young Investigator Award from the International Society for Magnetic Resonance in Medicine (ISMRM) given to “outstanding young investigators in the field of cancer MR” and the ISMRM’s Outstanding Teacher Award for 2014. He has advised over sixty students and is a much sought after mentor.
Please join us for a virtual information session to learn about the INBT’s Masters Industry Co-Op Program.
To broaden the practical training for Master of Science in Engineering (MSE) students in the Whiting School of Engineering, INBT collaborates with major industry partners to offer these students a six-month Co-Op opportunity that provides industry experience, a salary, and college credit. This program is currently only available to students in the Departments of Materials Science and Engineering, Mechanical Engineering, and Chemical and Biomolecular Engineering.
Go to the Masters Co-Op website to learn more about the program.
*The Co-Op program is still active during the COVID-19 pandemic.
Zoom information
Link: https://wse.zoom.us/j/92452322817
Webinar ID: 924 5232 2817
Telephone: Dial (for higher quality, dial a number based on your current location): US: 1-301-715-8592 or 1-646-558-8656 or 1-312-626-6799 or 1-253-215-8782 or 1-346-248-7799 or 1-669-900-6833
BME Presents: Ngan Huang, PhD
Assistant Professor of Cardioghoracic Surgery Research
Stanford University
Host: Warren Grayson & Sharon Gerecht
Engineering the Microsvasculature of Regenerative Medicine
Bio: Ngan F. Huang is an Assistant Professor in the Department of Cardiothoracic Surgery at Stanford University and Principal Investigator at the Veterans Affairs Palo Alto Health Care System. Dr. Huang completed her BS in Chemical Engineering from the Massachusetts Institute of Technology, followed by a PhD in bioengineering from the University of California Berkeley & University of California San Francisco Joint Program in Bioengineering. Prior to joining the faculty, she was a postdoctoral scholar in the Division of Cardiovascular Medicine at Stanford University. Her laboratory investigates the interactions between stem cells and extracellular matrix microenvironment for engineering cardiovascular tissues to treat cardiovascular and musculoskeletal diseases. Dr. Huang has authored over 70 publications and patents, including reports in Nat Med, PNAS, and Nano Lett. She has received numerous honors, including a NIH K99/R00 Career Development Award, Fellow of the American Heart Association, a Young Investigator award from the Society for Vascular Medicine, a Young Investigator Award from the Tissue Engineering and Regenerative Medicine International Society-Americas, and a Rising Star award at the Cell & Molecular Bioengineering conference. Her research is funded by the NIH, Department of Defense, California Institute of Regenerative Medicine, and Department of Veteran Affairs.
Event Link: https://www.bme.jhu.edu/news-events/bme-events/
For the third year, the INBT community is participating as a team in the Adopt-a-Family and Adopt-a-Senior program sponsored by the Johns Hopkins Benefits Office. Johns Hopkins partners with local nonprofit and service agencies to connect employees with families and senior citizens in need during the holiday season.
Due to the COVID-19 pandemic the program is only accepting gift cards. You can purchase a gift card for a senior citizen, family member, or both!
You can register here.
Join other women researchers for a discussion on the challenges women in STEM experience, and how to overcome them. Share your experiences, network, and learn from one another.
This is your chance to asked established women researchers questions you always wanted to ask in a safe and non-judgemental atmosphere. Claire Hur, Daniele Gilkes, and Karen Eisinger will share their experiences, advice, and challenges facing women in STEM. Come with question or listen to the discussion.
About the speakers
- Soojung Claire Hur is the Clare Boothe Luce Assistant Professor of Mechanical Engineering and associate faculty member at the INBT.
- Daniele Gilkes is an assistant professor in the Oncology Department, under the Breast and Ovarian Cancer Program, at Johns Hopkins. She is also an associate faculty member at the INBT and a researcher at the Johns Hopkins Physical Sciences-Oncology Center.
- Tzipora Sarah Karin Eisinger is the Ann B. Young Assistant Professor in Cancer Research University of Pennsylvania Perelman School of Medicine. She is also a researcher in the Johns Hopkins Physical Sciences-Oncology Center.
Registration
Register for the event on Eventbrite. Registration closes 11/17/2020 at 4:30 pm. A Zoom link and passcode will be emailed to registrants the day before the event. Anonymous questions, comments, and experiences can be submitted prior to the event.
The Johns Hopkins Translational Immunoengineering is hosting a workshop series in January.
The field of immunoengineering combines the diverse and complex fields of engineering and immunology and is transforming patient treatment in cancer, autoimmunity, regeneration, and transplantation. There is a significant need for training of engineers in immunology and for training immunologists in quantitative engineering techniques. Moreover, there is need to bridge basic immunological discoveries with advances in clinical application. This course will review the fundamentals of the immune system and its components, engineering strategies to modulate the immune system, and clinical applications. This workshop series is also being offered for CME credit and as a two-credit course for Hopkins students.
Go to their website to see schedule, speakers, topics, and registration information.
Join people at the Whiting School of Engineering during the week of February 21 through 27 for their annual celebration of engineering and the difference it makes in our world! Scheduled events are subject to change. All events are being held virtually. Register for events on the WSE website.
Aerospace Exploration – Monday, February 22
Tower of Power – Tuesday, February 23
Virtual Symposium on Human Spaceflight – Wednesday, February 24
Oil & Energy Panel – Wednesday, February 24
Speed Networking Night – Thursday, February 25
We welcome students to join the spring information session about our Masters Industry Co-Op program.
The information session will explain how the program provides students with career training while employed with an industry partner. Students gain work experience, network, and build technical skills that prepares them for a competitive job market. Plus, students earn a salary and receive college credit during employment. This program is open to engineering students in chemical and biomolecular engineering, materials science and engineering, and mechanical engineering. Go our Masters Co-Op webpage to learn more and then come with questions to session.
*The Co-Op program is still active during the COVID-19 pandemic offering both in-person and virtual experiences.*
Register for this event on Eventbrite. A Zoom link will be emailed the morning of the event. The event will be held in Eastern Standard Time.
Stem Cells for Cardiovascular Tissue Engineering and Repair
Please join to meet Yibing Qyang, associate professor of medicine (cardiology) and of pathology from Yale University.
Abstract: Mechanically robust vascular grafts are in urgent clinical demand for treating cardiovascular diseases or providing hemodialysis access. Vascular smooth muscle cells (VSMCs) can be derived in large numbers from human induced pluripotent stem cells (hiPSCs) for producing tissue-engineered vascular grafts (TEVGs). We will discuss the generation of hiPSC-derived TEVGs with mechanical strength comparable to native vessels used in arterial bypass grafts by utilizing biodegradable scaffolds, incremental pulsatile stretching, and optimal culture conditions. Following implantation into a rat aortic model, hiPSC-TEVGs show excellent patency without luminal dilation and effectively maintain mechanical and contractile function. To develop readily available vascular grafts, we have decellularized hiPSC-TEVGs based on an efficient decellularization approach. We have also successfully endothelialized decellularized hiPSC-TEVGs with hiPSC-derived ECs (hiPSC-ECs) under shear stress in a flow bioreactor. Immunologically “universal” hiPSCs will be discussed in order to make hiPSC-TEVG readily available for vascular treatment. Finally, the progress on exploring TEVGs as a potential treatment for single ventricle congenital heart defects will be shared. These studies may provide a foundation for future production of non-immunogenic hiPSC-TEVGs for treating cardiovascular diseases.
Biography: Yibing Qyang obtained his B.S. degree from the Department of Biochemistry, Nanjing University, China and subsequently pursued graduate studies at the Institute of Microbiology, Chinese Academy of Sciences. Then he joined the Department of Molecular Genetics, University of Texas M.D. Anderson Cancer Center. After receiving his M.S. degree from Dr. Michele Sawadogo’s laboratory, and his Ph.D. from Dr. Stevan Marcus’s lab, he spent the next year conducting postdoctoral research at Baylor College of Medicine, where he studied myeloproliferative diseases with a mouse model of presenilin deficiency. He next joined Dr. Kenneth R. Chien’s laboratory at the University of California, San Diego and then the Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School and Harvard Stem Cell Institute. He has been studying the renewal and differentiation of cardiovascular progenitor cells, marked by Isl1, a LIM-Homeodomain transcription factor, as well as cardiovascular disease mechanisms using human stem cell and animal models. In October 2008, Dr. Qyang became a principal investigator at the Yale Cardiovascular Research Institute and Section of Cardiology, Dept. of Internal Medicine, and Yale Stem Cell Center. Since 2010, he has been Director of the Yale Stem Cell Research Forum.
Zoom Information
Meeting URL: https://wse.zoom.us/j/93684553880
Meeting ID: 936 8455 3880
By Telephone
Dial: US: +1 301 715 8592 or
+1 312 626 6799 or
+1 646 558 8656 or
+1 346 248 7799 or
+1 669 900 6833 or
+1 253 215 8782
Meeting ID: 936 8455 3880
Please join us for the 14th Annual Nano-Bio Symposium on Engineering in Aging Research. Census data from the United States projects that by 2050 the 65 year-old population will double and about 20% of the population will be over 60 years old. A rapidly aging world is expected to induce socio-economic burdens, including age-associated diseases, disabilities, multi-morbidities, polypharmacy, and healthcare costs. Engineers are positioned to explore and provide solutions to these challenges and more to promote healthy aging and well-being.
See the full agenda, speakers, and register for the symposium.
